QTMeds

Drug Database Monograph

DARZALEX 1800 mg

PENDING REVIEW

Active Ingredient: DARATUMUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 60047225

← Back to Prescription Analyzer